Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation.
Pathogenic fungus Cryptococcus neoformans has a predilection for the central nervous system causing devastating meningoencephalitis. Traversal of C. neoformans across the blood-brain barrier (BBB) is a crucial step in the pathogenesis of C. neoformans. Our previous studies have shown that the CPS1 gene is required for C. neoformans adherence to the surface protein CD44 of human brain microvascular endothelial cells (HBMEC), which constitute the BBB. In this report, we demonstrated that C. neoformans invasion of HBMEC was blocked in the presence of G109203X, a protein kinase C (PKC) inhibitor, and by overexpression of a dominant-negative form of PKCalpha in HBMEC. During C. neoformans infection, phosphorylation of PKCalpha was induced and the PKC enzymatic activity was detected in the HBMEC membrane fraction. Our results suggested that the PKCalpha isoform might play a crucial role during C. neoformans invasion. Immunofluorescence microscopic images showed that induced phospho-PKCalpha colocalized with beta-actin on the membrane of HBMEC. In addition, cytochalasin D (an F-filament-disrupting agent) inhibited fungus invasion into HBMEC in a dose-dependent manner. Furthermore, blockage of PKCalpha function attenuated actin filament activity during C. neoformans invasion. These results suggest a significant role of PKCalpha and downstream actin filament activity during the fungal invasion into HBMEC.
Jong
Ambrose
A
Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA. ajong@chla.usc.edu
Wu
Chun-Hua
CH
Prasadarao
Nemani V
NV
Kwon-Chung
Kyung J
KJ
Chang
Yun C
YC
Ouyang
Yannan
Y
Shackleford
Gregory M
GM
Huang
Sheng-He
SH
D008841:Actin Cytoskeleton / Q000378:metabolism; D001812:Blood-Brain Barrier / Q000201:enzymology* / Q000382:microbiology / Q000473:pathology; D002196:Capillaries / Q000201:enzymology / Q000382:microbiology / Q000473:pathology; D002478:Cells, Cultured; D003455:Cryptococcus neoformans / Q000472:pathogenicity*; D004730:Endothelium, Vascular / Q000201:enzymology* / Q000382:microbiology / Q000473:pathology; D004789:Enzyme Activation; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D016919:Meningitis, Cryptococcal / Q000201:enzymology* / Q000382:microbiology / Q000473:pathology; D010766:Phosphorylation; D051571:Protein Kinase C-alpha / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
D007527:Isoenzymes; D051571:Protein Kinase C-alpha